
About Dayima
Dayima is a Healthcare company based in Beijing (China) founded in 2012 by Chai Ke. Periods and womens health are tracked via a mobile app. Dayima has raised $75.6 million across 8 funding rounds from investors including European Union, Haitong Securities and By-Health. Its focus areas include HealthTech, Disease Self Management, Women Health and Monitoring.
Company details
Dayima was founded in 2012 in Beijing, China, within the womens health technology sector. A mobile application is operated to track menstrual cycles based on historical data. Predictions for future periods are generated, alongside health advice for managing cramps and pre-menstrual symptoms. Connections to online forums are facilitated for user discussions on parenting, beauty, and related topics.
- Headquarters Beijing, China
- Founders Chai Ke
- SectorsHealthcare
- Website dayima.com
- Social LinkedIn
- Total Equity Funding$75.6M (USD)
in 8 rounds
- Latest Funding Round$160K (USD), Grant
Mar 2023
- InvestorsEuropean Union
& 6 more
Funding Insights of Dayima
Dayima has successfully raised a total of $75.6M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $160 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $75.6M
- Total Rounds 8
- Last Round Grant β $159,998
- First Round $5M
(Apr 2013)
- Investors Count 7
All 8 funding rounds of Dayima with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $159,998 | Grant | β | β | |
| Dec 2021 | Grant | β | β | ||
| Oct 2015 | $20.5M | Series E | β | β | |
| Jul 2015 | $10.1M | Series D | β | β | |
| Jun 2014 | $30M | Series C | β | Ceyuan Ventures | |
| Sep 2013 | $10M | Series B | β | Zhen Fund, Sequoia Capital | β |
| Aug 2013 | Series A | β | β | β | |
| Apr 2013 | $5M | Series A | β | Zhen Fund, BAI Capital | β |
7 investors in total: 7 institutional.
Investors in Dayima
Dayima has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Haitong Securities and By-Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech investments in China are managed by Ceyuan Ventures. | ceyuan.com | Hong Kong, China | ||
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
BAI Capital is engaged in investment and financial services. | bai-cap.com | Beijing, China | ||
Tech & Offline focused Seed stage VC Firm investing primarily in Asia and the US | zhenfund.com | Beijing, China | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Financial services such as brokerage and asset management are offered. | 1988 | htsec.com | Shanghai, China | |
Dietary supplements are manufactured by By-Health in China. | 1995 | by-health.com | Guangzhou, China |
Investor details for Dayima
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dayima
1 people are tracked at Dayima (1 in leadership).
| Name | Role | Group |
|---|---|---|
Chai Ke | Founder | Leadership |
Complete people profiles for Dayima
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dayima
3 dated milestones of Dayima across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Dayima is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Grant, of $160K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dayima
Dayima was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Dayima is headquartered in Beijing, China.
Dayima is a funded company, having raised a total of $75.6M across 8 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Apr 2013.
Dayima was founded in 2012 in Beijing, China, within the womens health technology sector. A mobile application is operated to track menstrual cycles based on historical data. Predictions for future periods are generated, alongside health advice for managing cramps and pre-menstrual symptoms. Connections to online forums are facilitated for user discussions on parenting, beauty, and related topics.
Dayima has 7 investors. Key investors include European Union, Haitong Securities, By-Health, Ceyuan Ventures, and Sequoia Capital.